首页> 美国卫生研究院文献>BMC Cancer >Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system
【2h】

Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system

机译:根据第七版AJCC分期系统对N0型鼻咽癌患者进行调强放射治疗的有希望的治疗结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundIntensity-modulated radiation therapy (IMRT) provides excellent locoregional control for nasopharyngeal carcinoma (NPC), and has gradually replaced two-dimensional conventional radiotherapy as the first-line radiotherapy technique. Furthermore, in the new seventh edition of the American Joint Committee on Cancer (AJCC) staging system, retropharyngeal lymph nodes were upgraded from N0 to N1 disease as a result of their negative impact on the distant metastasis-free survival (DMFS) rates of NPC. This retrospective study was conducted in order to review the treatment outcomes and patterns of failure in NPC patients with N0 disease after IMRT in order to effectively guide treatment in the future.
机译:背景调强放射治疗(IMRT)为鼻咽癌(NPC)提供了出色的局部区域控制,并已逐渐取代二维常规放射治疗作为一线放射治疗技术。此外,在新的第七版美国癌症联合委员会(AJCC)分期系统中,咽后淋巴结从N0升级为N1疾病,因为它们对NPC的无远处转移生存(DMFS)率产生了负面影响。进行这项回顾性研究的目的是回顾IMRT后N0病的NPC患者的治疗结果和失败模式,以便在将来有效地指导治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号